ro13-9904 and Mastitis

ro13-9904 has been researched along with Mastitis* in 2 studies

Other Studies

2 other study(ies) available for ro13-9904 and Mastitis

ArticleYear
Pharmacokinetics and Efficacy of Ceftriaxone in Staphylococcal Mastitis in Crossbred Cows Following Single Intravenous Administration.
    Current drug metabolism, 2021, Volume: 22, Issue:5

    Clinical mastitis is an important production disease of dairy animals, causing significant economic losses.. Disposition kinetics of ceftriaxone was conducted in healthy lactating and staphylococcal mastitic crossbred cows in field condition following single-dose intravenous administration of only ceftriaxone.. A single dose of ceftriaxone at 20 mg kg. Ceftriaxone may prove to be effective in the treatment of staphylococcal mastitis in crossbred cows following single-dose intravenous administration at 20 mg kg

    Topics: Administration, Intravenous; Animals; Anti-Bacterial Agents; Cattle; Ceftizoxime; Ceftriaxone; Female; Lactation; Mastitis; Milk; Staphylococcal Infections; Staphylococcus aureus

2021
    BMJ case reports, 2019, Apr-08, Volume: 12, Issue:4

    Topics: Abscess; Adult; Anti-Bacterial Agents; Biopsy; Ceftriaxone; Drainage; Female; Humans; Mastitis; Salmonella Infections; Salmonella paratyphi A; Ultrasonography

2019